Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
BioAtla | 116 | 2023q3 | |||||||||
Biogen | 25,166 | 2023q2 | |||||||||
BioLife Solutions | 1,151 | 2023q3 | |||||||||
BioLineRx | 2,070 | 2021 | |||||||||
BioMarin Pharmaceutical | 16,017 | 2023q2 | |||||||||
Bionano Genomics | 11 | 2023q3 | |||||||||
BioNTech | 25,650 | 2024q2 | |||||||||
Bio-Rad Laboratories | 10,214 | 2023q3 | |||||||||
Bio-Techne | 10,431 | 2024q2 | |||||||||
BioXcel Therapeutics | 17 | 2022 | |||||||||
Black Diamond Therapeutic... | 176 | 2023q3 | |||||||||
bluebird bio | 150 | 2023q3 | |||||||||
Blueprint Medicines | 5,358 | 2022 | |||||||||
Bolt Biotherapeutics | 46 | 2023q3 | |||||||||
Boston Scientific | 114,511 | 2024q2 | |||||||||
BrainStorm Cell Therapeut... | 21 | 2021 | |||||||||
BridgeBio Pharma, Inc | 4,631 | 2023 | |||||||||
Bristol-Myers Squibb | 107,781 | 2023q3 | |||||||||
Bruker | 13,778 | 2022 | |||||||||
Burning Rock Biotech | 774 | 2024q1 |